Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2024 -15.89M
December 31, 2023 -17.06M
June 30, 2023 -15.35M
December 31, 2022 12.46M
Date Value
June 30, 2022 14.64M
December 31, 2021 -12.96M
June 30, 2021 -20.42M
December 31, 2020 -28.60M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
InflaRx NV -27.64M
BioNTech SE -563.78M
Immatics NV -259.47M
Oncolytics Biotech, Inc. -28.39M
Sangamo Therapeutics, Inc. -90.46M